Premium
P3‐252: FGF 21 IS ONE OF THE FACTORS ASSOCIATED WITH COGNITIVE DECLINE IN NONELDERLY PATIENTS WITH METABOLIC SYNDROME
Author(s) -
Phrommintikul Arintaya,
Sa-nguanmoo Piangkwan,
Sripetchwandee Jirapas,
Vathesatogkit Prin,
Chattipakorn Nipon,
Chattipakorn Siriporn C.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1612
Subject(s) - fgf21 , medicine , montreal cognitive assessment , waist , metabolic syndrome , body mass index , cognitive decline , cognition , risk factor , gerontology , obesity , cognitive impairment , fibroblast growth factor , disease , psychiatry , dementia , receptor
BMI: body mass index; FGF21: fibroblast growth factor 21; HbA1C: Glycated hemoglobin A1C; HDL-C: high density lipoprotein cholesterol HOMA index: Homeostasis Model Assessment index; LDL-C: low density lipoprotein cholesterol; MoCA: Montreal cognitive assessment; SBP: systolic blood pressure. Oliver Preische, Stephanie A. Schultz, Anja Apel, Jens Kuhle, Brian A. Gordon, Guoqiao Wang, Eric McDade, Randall J. Bateman, John C. Morris, Tammie L. S. Benzinger, Mathias Jucker, Department of Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany; Washington University in St. Louis School of Medicine, St. Louis, MO, USA; German Center for Neurodegenerative Diseases, Tuebingen, Germany; Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany; University Hospital Basel, Basel, Switzerland; Knight Alzheimer’s Disease Research Center, St. Louis, MO, USA; Washington University School of Medicine, St. Louis, MO, USA; Washington University School of Medicine, Saint Louis, MO, USA. Contact e-mail: saschultz@wustl.edu